Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine

Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine

This single-center study included 68 multiple sclerosis (MS) patients who received the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination from one of several approved vaccine preparations in Spain. Blood samples were collected one to three months after the second dose of the va...

Full description

Bibliographic Details
Main Authors: Alexander Rodero-Romero, Susana Sainz de la Maza, José Ignacio Fernández-Velasco, Enric Monreal, Paulette Esperanza Walo-Delgado, Juan Luis Chico-García, Noelia Villarrubia, Fernando Rodríguez-Jorge, Rafael Rodríguez-Ramos, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Vaccines
Subjects:
cellular immune response
SARS-CoV-2 vaccination
multiple sclerosis
disease-modifying therapies
Online Access:https://www.mdpi.com/2076-393X/11/9/1399

Internet

https://www.mdpi.com/2076-393X/11/9/1399

Similar Items